Literature DB >> 16002693

Failure of CD25+ T cells from lupus-prone mice to suppress lupus glomerulonephritis and sialoadenitis.

Harini Bagavant1, Kenneth S K Tung.   

Abstract

The development of organ-specific autoimmune diseases in mice thymectomized on day 3 of life (d3tx mice) can be prevented by transferring CD4(+)CD25(+) T cells from syngeneic, normal adult mice. Using a d3tx model, we asked whether CD4(+)CD25(+) T cell deficiency contributes to glomerulonephritis (GN) in lupus-prone mice. New Zealand Mixed 2328 (NZM2328) mice spontaneously develop autoantibodies to dsDNA and female-dominant, fatal GN. After d3tx, both male and female NZM2328 mice developed 1) accelerated dsDNA autoantibody response, 2) early onset and severe proliferative GN with massive mesangial immune complexes, and 3) autoimmune disease of the thyroid, lacrimal gland, and salivary gland. The d3tx male mice also developed autoimmune prostatitis. The transfer of CD25(+) cells from 6-wk-old asymptomatic NZM2328 donors effectively suppressed dsDNA autoantibody and the development of autoimmune diseases, with the exception of proliferative lupus GN and sialoadenitis. This finding indicates that NZM2328 lupus mice have a selective deficiency in T cells that regulates the development of lupus GN and sialoadenitis. After d3tx, the proliferative GN of female mice progressed to fatal GN, but largely regressed in the male, thereby revealing a checkpoint in lupus GN progression that depends on gender.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002693     DOI: 10.4049/jimmunol.175.2.944

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  36 in total

Review 1.  The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature.

Authors:  M Jallouli; D Saadoun; B Eymard; G Leroux; J Haroche; D Le Thi Huong; C De Gennes; C Chapelon; O Benveniste; B Wechsler; P Cacoub; Z Amoura; J C Piette; N Costedoat-Chalumeau
Journal:  J Neurol       Date:  2011-12-08       Impact factor: 4.849

Review 2.  Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?

Authors:  Qin Lan; Huimin Fan; Valerie Quesniaux; Bernhard Ryffel; Zhongmin Liu; Song Guo Zheng
Journal:  J Mol Cell Biol       Date:  2011-11-22       Impact factor: 6.216

3.  Anti-CD3 antibody therapy attenuates the progression of hypertension in female mice with systemic lupus erythematosus.

Authors:  Keisa W Mathis; Erin B Taylor; Michael J Ryan
Journal:  Pharmacol Res       Date:  2017-04-08       Impact factor: 7.658

Review 4.  Role of T cells and dendritic cells in glomerular immunopathology.

Authors:  Christian Kurts; Felix Heymann; Veronika Lukacs-Kornek; Peter Boor; Jürgen Floege
Journal:  Semin Immunopathol       Date:  2007-10-23       Impact factor: 9.623

5.  Autoantibody production in lpr/lpr gld/gld mice reflects accumulation of CD4+ effector cells that are resistant to regulatory T cell activity.

Authors:  Brian D Hondowicz; Michele L Fields; Simone A Nish; Joseph Larkin; Andrew J Caton; Jan Erikson
Journal:  J Autoimmun       Date:  2008-06-09       Impact factor: 7.094

6.  Regulatory T cells vs Th17: differentiation of Th17 versus Treg, are the mutually exclusive?

Authors:  Song Guo Zheng
Journal:  Am J Clin Exp Immunol       Date:  2013-02-27

7.  Interaction between innate immunity and Ro52-induced antibody causes Sjögren's syndrome-like disorder in mice.

Authors:  Barbara M Szczerba; Paulina Kaplonek; Nina Wolska; Anna Podsiadlowska; Paulina D Rybakowska; Paromita Dey; Astrid Rasmussen; Kiely Grundahl; Kimberly S Hefner; Donald U Stone; Stephen Young; David M Lewis; Lida Radfar; R Hal Scofield; Kathy L Sivils; Harini Bagavant; Umesh S Deshmukh
Journal:  Ann Rheum Dis       Date:  2015-02-05       Impact factor: 19.103

Review 8.  Immune system in renal injury and repair: burning the candle from both ends?

Authors:  Michael S Goligorsky
Journal:  Pharmacol Res       Date:  2008-06-08       Impact factor: 7.658

9.  Effect of modified Zhuye Shigao Decoction and its components on preventing radiation esophagitis of rats.

Authors:  Jun-zhang Lu; Chen Wang; Ming-hui Yang; Hong Zhao; Yi Liu; Xiu-tang Cao
Journal:  Chin J Integr Med       Date:  2014-06-21       Impact factor: 1.978

10.  Caerulomycin A enhances transforming growth factor-β (TGF-β)-Smad3 protein signaling by suppressing interferon-γ (IFN-γ)-signal transducer and activator of transcription 1 (STAT1) protein signaling to expand regulatory T cells (Tregs).

Authors:  Rama Krishna Gurram; Weshely Kujur; Sudeep K Maurya; Javed N Agrewala
Journal:  J Biol Chem       Date:  2014-05-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.